Skip to main content
Dryad logo

Data from: Progressive parkinsonism in older adults is related to the burden of mixed-brain pathologies

Citation

Buchman, Aron S. et al. (2019), Data from: Progressive parkinsonism in older adults is related to the burden of mixed-brain pathologies, Dryad, Dataset, https://doi.org/10.5061/dryad.vn42tj2

Abstract

Objective: To examine if indices of Parkinson’s disease (PD) pathology and other brain pathologies are associated with the progression of parkinsonism in older adults. Methods: We used data from decedents who had undergone annual clinical testing prior to death and structured brain autopsy. Parkinsonism was based on assessment with a modified United Parkinson’s Disease Rating Scale and a clinical diagnosis of PD was based on medical history. We employed a series of mixed-effects models controlling for age and sex, to investigate the association of PD pathology (nigral neuronal loss and Lewy bodies) and indices of eight other brain pathologies with the progression of parkinsonism prior to death. Results: During an average of 8.5 years follow-up, more than half (771/1430, 53.9%) developed parkinsonism proximate to death. On average, parkinsonism was progressive (Estimate, 0.130, S.E., 0.005, p<0.001) in all older adults, but more rapid in adults with a clinical diagnosis of PD [N=52; 3.6%] (Estimate, 0.066 S.E., 0.021, p<0.001). Progression of parkinsonism was more rapid in adults with PD pathology (Estimate, 0.087, S.E., 0.013, p<0.001) Alzheimer’s disease (AD), and several cerebrovascular pathologies were all independently associated with more rapid progression (all p-Values <0.05). The association between a higher person-specific weighted pathology score and more rapidly progressive parkinsonism did not differ between individual’s with and without a clinical diagnosis of PD (Estimate 0.003, S.E., 0.047, p=0.957). Conclusion: The rate of progressive parkinsonism in older adults with and without a clinical diagnosis of PD is related to the burden of mixed-brain pathologies.

Usage Notes

Location

United States